Rheumatoid arthritis (RA) is a systemic inflammatory disorder, with the most common extra-
articular manifestation of RA being lung involvement. While essentially any of the lung …

Objective To review published cases of induced or exacerbated interstitial lung disease
(ILD) in rheumatoid arthritis (RA) associated with non-biologic disease-modifying …

Rheumatoid arthritis (RA) is often characterized by the burden of swollen joints, pain, and
decreased physical function, but less understood are the many manifestations of additional …

Pneumonitis is a serious and unpredictable side-effect of treatment with methotrexate (MTX)
that may become life-threatening. The clinical and histological features of nine cases of MTX …

Objective. To describe the clinical, laboratory, radiologic, and histopathologic features of
methotrexate (MTX)‐induced lung injury in a combined cohort of selected patients with …

Background: Toxicity limits the use of methotrexate. Objective: To identify risk factors for
methotrexate-induced lung injury in patients with rheumatoid arthritis. Design: Case-control …

Objective: To determine the effect of two different weekly doses of folic acid on the toxicity
and efficacy of low-dose methotrexate therapy for rheumatoid arthritis. Design: Randomized …

MTX, which is the anchor-drug for the treatment of RA, has been associated with lung injury
and in particular with MTX-related pneumonitis (M-pneu). Although the frequency of M-pneu …

Rheumatoid arthritis (RA) is a progressive, systemic autoimmune disorder characterized by
articular and extra-articular manifestations. The lung is commonly a site of extra-articular …

Background: Rheumatoid arthritis (RA)-related comorbidities, including cardiovascular
disease (CVD), osteoporosis (OP), and interstitial lung disease (ILD), are sub-optimally …